Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
01 2Bloomage Biotechnology corp., Ltd.
02 1HTL
03 1HTL SAS
04 1Shandong Topscience Biotech Co., Ltd.
05 1AMHWA Biopharm Co.,Ltd
06 2Contipro a.s.
07 1DARMERICA, LLC
08 1MEDISCA Inc.
09 1Medisca Inc.
10 1Spectrum Laboratory Products, Inc.
01 4HYALURONATE SODIUM
02 1Hyaluronate sodium
03 6Sodium Hyaluronate
04 1Sodium Hyaluronate type II
01 4China
02 2Czech Republic
03 2France
04 4U.S.A
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
NDC Package Code : 67828-0000
Start Marketing Date : 2014-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
NDC Package Code : 51035-001
Start Marketing Date : 2014-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.
NDC Package Code : 84109-001
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
NDC Package Code : 67828-0001
Start Marketing Date : 2014-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
NDC Package Code : 51035-002
Start Marketing Date : 2014-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 40004-002
Start Marketing Date : 2012-10-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 40004-001
Start Marketing Date : 2007-08-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2231
Start Marketing Date : 2017-04-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2860
Start Marketing Date : 2015-05-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-6777
Start Marketing Date : 2023-10-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Hyaluronate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyaluronate Sodium, including repackagers and relabelers. The FDA regulates Hyaluronate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyaluronate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hyaluronate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hyaluronate Sodium supplier is an individual or a company that provides Hyaluronate Sodium active pharmaceutical ingredient (API) or Hyaluronate Sodium finished formulations upon request. The Hyaluronate Sodium suppliers may include Hyaluronate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Hyaluronate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hyaluronate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hyaluronate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hyaluronate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hyaluronate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hyaluronate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hyaluronate Sodium suppliers with NDC on PharmaCompass.
We have 8 companies offering Hyaluronate Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?